Position in LQDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$79,730
New position
Shares Held
1,000
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#276
of 333 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HOLLENCREST CAPITAL MANAGEMENT holds $310,202 across 9 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (25.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,569 | $151,955 | |
| 2 | LQDA |
Liquidia Corp
This page
|
1,000 | $79,730 | |
| 3 | HROW |
Harrow, Inc.
|
1,300 | $55,211 | |
| 4 | AQST |
Aquestive Therapeutics, Inc.
|
3,000 | $12,480 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
80 | $3,720 | |
| 6 | ZTS |
Zoetis Inc.
|
44 | $3,161 | |
| 7 | CRON |
Cronos Group Inc.
|
575 | $1,598 | |
| 8 | HLN |
Haleon plc
|
147 | $1,371 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $79,730 | 1,000 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||